Ross St C Barnetson, professor of dermatologya, Maureen Rogers, paediatric
dermatologistb.
a Department of Dermatology, Royal Prince Alfred Hospital,
Camperdown NSW 2050, Australia, b Department of Dermatology, New
Children's Hospital, Westmead, Sydney, Australia
Atopic eczema is a common condition that affects more than one in ten
children in developed countries, and the incidence isincreasing.
There are probably several reasons for this, includinghigher
exposure to air pollution, smaller families with less exposureto
infections, more pets, higher maternal age, and a wider rangeof
foods. There is clearly also an important hereditary componentto
atopic eczema. This is complex because not all affected childrenare
atopic, though the genes implicated in atopy are likely tobe
involved, together with others as yet unknown. Atopic eczemausually
presents during the first year of life, and when it issevere it is
extremely disabling. It may also cause major psychologicalproblems.
Most affected children are also allergic to house dustmite, and this
is probably a major cause of exacerbation of thecondition. Probably
less than 10% overall have IgE mediated foodallergy, but some have
late phase reactions with positive resultson patch tests to foods.
Summary points
Atopic eczema in children is a complex condition
Four in five children with atopic eczema have IgE mediated allergy to
inhalants or foods
House dust mite exacerbates atopic eczema
Food allergy exacerbates eczema in less than one in ten children
To reduce the need for admission to hospital children with severe
eczema can be treated with topical or oral immunosuppression
We searched Medline for entries on atopic eczema and atopic dermatitis in
children and adults. We also relied on our personalexperience in
treating children with atopic eczema over the past30years.
Fig 1. Incidence of different
types of atopy by age (adapted with permission from W B Saunders1)
There is a wide spectrum of presentations of atopic eczema, from minimal
flexural eczema (fig 2) to erythroderma. The skin
of a child with eczema is generally dry. The eczema can occur
anywhere, but there are particular patterns that are more commonat
certain ages. The face is usually the first to be affected(fig
3). In crawling infants the forearms, extensor aspects ofthe knees, and the ankle flexures are often the most affected.
In older children the flexor aspects of the elbows and the kneesare
mostly affected. The eczema may be moist and weeping or maybe
thickened (lichenified) and dry. In children with darker skinthe
rash may have a papular nature. Scratch marks are always seen.The
course of the condition fluctuates: causes of exacerbationsmay be
evident but usually arenot.
Infective complications are common. Staphylococcal infection may manifest as
typical bullous impetigo or simply as a worseningof the eczema with
increased redness and oozing. Staphylococcalfolliculitis may occur
as a result of occlusion from greasy emollientsor wet dressings.
Streptococcal infection may manifest as increasedredness and erosion
of the skin or as pustular lesions. Atopicchildren are particularly
prone to severe widespread herpes simplexinfections; the spread of
the condition is mainly systemic butthe areas most affected are the
areas of activeeczema.
The child's life is limited by the constraints of care of the skin, which can
separate the child from his or her peers.2This can include sport, swimming, and dietary restrictions. The
child feels unattractive and different and may have problems with
self image and self confidence.
The relationship of the child and the parents may be adversely affected
because:
The child is not physically attractive
Touch, which is so important to bonding, is unpleasant as the skin feels
rough
The child avoids physical contact because of their dislike of the
application of creams and dressings
The child uses scratching as a weapon, when crossed or denied something
Relationships between parents and within the family become strained
because of the amount of attention given to one child
Inhalant allergens
Most children with eczema are atopic and aretherefore allergic to
inhalants such as house dust mite (Dermatophagoidespteronyssinus),
grass pollens, and animal dander. Some childrendevelop eczema on the
face during the pollen season, and manyparents report that their
child's eczema is worse after closecontact with pets. The highest
proportion of IgE is produced againsthouse dust mite, and this must
be the most important allergenin the exacerbation of eczema.3
House dust mite is present in large numbers in children's beds and as well as
causing asthma causes exacerbations of eczema.Several studies have
shown that actions to reduce dust mite numbersare associated with
amelioration of eczema.4 This is not surprisingas in children highly allergic to the mites, skin contact is boundto have a deleterious effect on the eczema. The role of delayed
hypersensitivity to house dust mite is also likely to be important.
People with atopic eczema have positive results to patch tests5and positive lymphoproliferative responses to the mite. Unfortunately,in everyday life minimisation of house dust mite in bedding is
difficult toachieve.
Food allergy and intolerance
In general, food allergy is caused by immunologicalmechanisms, food
intolerance is not. Food intolerance is relativelycommon: certain
chemicals in foods may cause worsening of theeczemafor
example, tartrazine or other colourings in foodbymechanisms that areunclear.
Food allergy is age dependent. It may be severe in the infant and become less
so with age. Allergy to some foods (such asegg and cows' milk) is
relatively transient, whereas allergy topeanuts or shellfish may
continue throughout life.
The association between atopic eczema and food allergy is complex, though it
is usually children with severe atopic eczemawho have food allergy.
Probably less than 10% of all childrenwith atopic eczema have IgE
mediated food allergy with angioedemaand urticaria, when the
diagnosis is obvious from the immediacyof the symptoms and can be
confirmed by a wheal >5 mm in diameterafter a skin prick test. Some
of these children have multiplefood allergies. There is no doubt
that IgE mediated food allergycan act as a trigger for exacerbations
of eczema,6 but mostparents recognise
the allergy and the food is avoided. What isnot clear is the role of
late phase food reactions, which causeexacerbations of the eczema
without urticaria or angioedema. Thesecan be confirmed by atopy
patch tests7 and food provocationtests.
This is receiving increasing attention.
Food allergy and
atopic eczema
Less than 10% of children with atopic eczema have food allergy or food
intolerance as exacerbating factors
Food allergy may be IgE mediated, giving an immediate reaction
Food allergy may be a late phase reaction, as proved by atopy patch tests
Food intolerance to ingested chemicals such as colourings (for example,
tartrazine) may occur and are not immunologically mediated
Exclusion diets are helpful in a small proportion of children with atopic
eczema.
Irritants
Woollen material in direct contact with theskin is a major irritant.
Shiny nylon materials and some acrylicsmay irritate, but
cotton-polyester mixtures are usually well tolerated.Soap in excess
and bubble baths excessively dry the skin, andmany perfumed and
"medicated" products applied to the skin willcause irritation. Some
of the plant extract preparations favouredby alternative
practitioners act as irritants or allergens anda query about the use
of these should always be part of the historytaking.
Explanation and counselling are a vital part of the successful management of
childhood eczema. Parents will have receiveda barrage of advice from
a range of medical, paramedical, andnon-medical "experts" and
require a clear understanding of thenature of the condition, a long
term management plan, and a realisticexpectation of the results oftreatment.
Terminology is often confusing; the terms atopic eczema and atopic dermatitis
are often used synonymously. It is essentialto talk in terms of
control rather than cure, otherwise parentswill search for an end
point after which care will no longer berequired, and this is an
unrealistic expectation. The conditionshould be explained as a
multifactorial disorder, and it mustbe appreciated that just as
there is no "cure" there is no single"cause." Often no explanation
can be found for a particular flareup of the condition, and many
factors are probably working incombination at alltimes.
Dealing with dryness
Bath oils and products containing oatmealare useful and prevent the
drying of the skin that bathing caninduce. Bath oils that contain
antiseptic may have added benefitin certain cases but have a
tendency to overdry and sometimesactually irritate the skin. The
child should have either a bathwith additive or a short shower. It
is essential to find a suitablemoisturiser that can be applied all
over twice a day whether ornot there is active eczema. Creams
containing cetomacrogol, emulsifyingointment, and creams or
ointments with lanolin can be used. Ifa product stings the skin it
must be abandoned. The most likelyirritant in emollient creams is
the stabiliser propylene glycol.Products that contain urea almost
always sting broken skin andare unsuitable in these
children.
Use of wet dressings
Wet dressings are useful in children withsevere widespread eczema.8
This is essentially an inpatientprocedure but can be used for short
periods at home. A water basedemollient is applied all over; a
corticosteroid cream (ratherthan ointment in this case because cream
is more water miscible)is applied to the areas of active eczema. The
creams are coveredwith a double layer of wrapping, the innermost of
which is wettedwith tepid water. The material may be cotton sheeting
coveredwith a crepe bandage, though an easier alternative is the useof a double layer of tubular elasticated bandage. The procedure
is repeated three times a day. This treatment is usually effectivein
clearing the eczema in three or fourdays.
Avoidance of allergens
House dust mite is the most important allergen.Avoidance measures
have to be carried out assiduously and mustinclude encasing the
mattress and pillows as well as dealing withthe top covers, either
by encasement or by hot (>60°C)washing.
If food allergy is suspected, the child should be referred to a paediatric
dietician. In general, it is children with severeatopic eczema who
have food allergy or food intolerance. Childrenwith flexural eczema
are unlikely to have food allergy, unlessthe history suggestsotherwise.
Topical corticosteroids
It is often necessary to spend some time counsellingthe parents that
topical steroid preparations used appropriatelyare safe. The
strength chosen depends on the severity of the eczemaand the site
affected. The frequency of application depends onthe individualproduct.
Topical antibacterials Staphylococcus aureus is commonly culturedfrom eczematous
skin, and there may be obvious signs of infection.For localised
infections, fusidic acid ointment may be effective.To prevent
infections it is useful to bathe the child in preparationscontaining
triclosan9 or benzalkoniumchloride.
Topical immunosuppressants
Tacrolimus is a potent immunosuppressive drugused in organ
transplantation. A topical formulation has beenshown to be effective
in trials in patients with moderate to severeatopic dermatitis. Two
studies specifically related to childhoodeczema have confirmed its
efficacy. 1011 The
main side effectis a sensation of burning. A concern has been raised
as to whetherapplication to skin exposed to sun could increase the
long termrisk of skincancer.
Pimecrolimus (an ascomycin derivative) is a newer immunosuppressive agent,
similar to tacrolimus. Preliminary studies in childrenlook
encouraging.12
Oral medications
Immunosuppressive drugs
Severe atopic eczema is a serious condition,with huge loss of
quality of life for the child on a par withjuvenile rheumatoid
arthritis. It is therefore essential thatsuch children are treatedadequately.
The use of oral steroids should be avoided because of severe rebound of the
eczema on withdrawal, the eczema becoming unstableafter several
courses, and the long term side effects. There aregenerally two
alternatives for severe eczema, cyclosporin andazathioprine.
CiclosporinRecent
studies have confirmed the efficacy of ciclosporin in childhood atopic eczema.
1314 Regrettably
theimprovement is often not maintained after withdrawal of the drug.Continuous treatment is rarely justified in view of the long termrisks (such as hypertension and renal dysfunction). However, it
has a place as an effective, safe, and well tolerated short term
option for the management of severe refractory disease in children.
Additional educational
resource
Brehler R, Hildebrand A, Luger T. Recent developments in treatment of
atopic eczema. J Am Acad Dermatol 1997;36:983-94
Information for patients
National Eczema Society (www.eczema.org).
One of the most established organisations dedicated to the needs of people
with eczema, dermatitis, and sensitive skin. The website is a good general
site with free information for people with eczema and dermatitis.
Eczema voice (www.eczemavoice.com).
This site was set up by parents of a boy with eczema and provides useful
information and support for other parents.
Talk eczema (www.talkeczema.com).
A free online support service for people with eczema and their families.
There is a useful dedicated area for young people.
babyworld (www.babyworld.co.uk).
Though this is a general site about pregnancy, birth, and babies, it also
contains useful information about eczema in babies, with frequently asked
questions and shared experiences.
Azathioprine is a safer drug for long term use, though it does have
several side effects, including nausea, fatigue, myalgia,and liver
dysfunction. It is used by paediatric dermatologistsin the United
Kingdom.15 It is essential to assay for thiopurinemethyl transferase before treatment starts as children deficientin this enzyme will experience marked bone marrow suppression.
In most children it is effective at low dosage. The main longterm
side effect that could theoretically occur (as with ciclosporin)is
the development of lymphoma. The advantage of this drug isthat it
can be usedcontinuously.
Other possibilities include the leukotriene inhibitors zafirlukast16
and montelukast,17 given orally. Chinese herbal
medicineshave also been used successfully but are not without
danger.18
Antihistamines
Sedating antihistamines such as alimemazineand promethazine given at
bedtime are both useful. The sedationis an important feature of
their antipruritic action. It is stilldebatable whether non-sedating
antihistamines such as cetirizineand loratadine are useful because
generally the role of histaminein eczema is somewhat limited.
However, a large study of the useof cetirizine in adults with atopic
eczema showed a significantreduction of clinical manifestations in
those treated.19
Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind
controlled trial of effect of housedust-mite allergen avoidance on atopic
dermatitis. Lancet 1996; 347: 15-18[Medline].
Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills
T. Basophils in allergen-induced patch test sites in atopic dermatitis.
Lancet 1982; i: 127-130.
Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson
HA. Prevalence of IgE-mediated food allergy among children with atopic
dermatitis. Pediatrics 1998; 101: E8.
Roehr CC, Reibel S, Ziegert M, Sommerfield C, Wahn U,
Niggemann B. Atopy patch tests, together with determination of specific IgE
levels, reduce the need for oral food challenges in children with atopic
dermatitis. J Allergy Clin Immunol 2001; 107: 548-553[Medline].
Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY,
Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment
for the treatment of atopic dermatitis in children. J Allergy Clin
Immunol 1998; 102: 637-644[Medline].
Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM.
Long-term safety and efficacy of tacrolimus ointment for the treatment of
atopic dermatitis in children. J Am Acad Dermatol 2001; 44(suppl 1):
S58-S64[Medline].
Harper J, Green A, Scott G, Gruendl E, Dorobek B, Cardno M,
Burtin P. First experience of topical SDZ ASM 981 in children with atopic
dermatitis. Br J Dermatol 2001; 144: 781-787[Medline].
Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H,
Lewis-Jones S, et al. Cyclosporine in severe atopic dermatitis: a
multicenter study. J Am Acad Dermatol 1996; 34: 1016-1021[Medline].
Harper JI, Berth-Jones J, Camp RDR, Dillon MJ, Finlay AY,
Holden CA, et al. Cyclosporin for atopic dermatitis in children.
Dermatology 2001; 203: 3-6[Medline].
Murphy LA, Atherton DJ. Azathioprine in severe childhood
eczema: value of TPMT as a predictor of outcome and safety in treatment.
Br J Dermatol 2001; 144: 927.
Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE.
The leucotriene antagonist zafirlukast as a therapeutic agent for atopic
dermatitis. Arch Dermatol 1998; 134: 785-786[Medline].
Pei AY, Chan HH, Leung TF. Montelukast in the treatment of
children with moderate-to-severe atopic dermatitis: a pilot study.
Pediatr Allergy Immunol 2001; 12: 154-158[Medline].
Hannuksela M, Kalimo K, Lammintausta K, Mattila T,
Turjanmaa K, Varjonen E, et al. Dose ranging study: cetirizine in the
treatment of atopic dermatitis in adults. Ann Allergy 1993; 70:
127-133[Medline].
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"